Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nandrolone decanoate and leucine supplementation to attenuate muscle loss during short-term immobilisation
2015-000578-37Phase 4Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nandrolone and l-leucine in muscle disuse atrophy, sponsored by Maastricht University Medical Center+. Primary endpoint: Quadriceps muscle cross-sectional area. Started Apr 2015; status: completed.
02
Drugs
nandrolonel-leucine
03
Conditions
muscle disuse atrophy
Beyond the preview
Go deeper on 2015-000578-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000578-37.